BAVENCIO is a prescription medicine used to treat:
- a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread. This indication is approved under accelerated approval based on a clinical trial that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in ongoing clinical trials
- a type of cancer in the bladder or urinary tract called urothelial carcinoma (UC) when it has spread or cannot be removed by surgery (advanced UC). BAVENCIO may be used:
- as maintenance treatment when your cancer has responded or stabilized after you have received platinum-containing chemotherapy as your first treatment
- when you have received platinum-containing chemotherapy, and it did not work or is no longer working
It is not known if BAVENCIO is safe and effective in children under the age of 12.